drugset / Trial / NCT05749666

Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis

NCT05749666

Phase 3 Unknown 50 enrolled Chinese SLE Treatment And Research Group
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a prospective, double-blinded, single center, randomized clinical trial. It compares the clinical efficacy and safety of thees 2 drugs in the treatment of active Takayasu's arteritis patients.

Timeline

Start
2023-01-20
Primary completion
2025-07-20
Completion
2025-07-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified
Subject Tofacitinib Small molecule 5 mg Oral

Indications